ArticleProstate cancer and prostatic diseases2020

Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml.

Ewa Witkowska-Patena et al.PubMed ↗Publisher ↗

No numbers read from the abstract.